Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Multiple randomised, placebo-controlled trials have tested GLP-1 drugs as add-on therapy to insulin in people with T1D, and the picture that emerges is consistent, if modest: meaningful weight loss, real reductions in daily insulin needs, and improvements in CGM time in range
Empowering Patients through Education Empowering patients with knowledge about their treatment options is crucial for informed decision-making
Glutathione (GSH) is the major free radical scavenger in the brain, lower levels of this antioxidant elevate cellular vulnerability to oxidative stress
Metabolic dysfunctionassociated steatohepatitis (MASH) is not just a liver condition - its deeply connected to obesity, insulin resistance, and cardiovascular disease
In places like Ethiopia, high Hcy is linked to high blood pressure due to limited access to fresh produce
US$ 22.86
US$ 24.29
US$ 20.29
